MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$12,691K
(-74.95%↓ Y/Y)
Other (income)
expense, net
$1,519K
(-76.84%↓ Y/Y)
Interest income
$211K
(-24.37%↓ Y/Y)
Loss from operations
-$10,223K
(-1.23%↓ Y/Y)
Interest expense
$4,198K
(5.13%↑ Y/Y)
Product revenue, net
$206K
(22.62%↑ Y/Y)
Total operating
expenses
$10,429K
(1.58%↑ Y/Y)
Selling, general and
administrative
$7,191K
(26.18%↑ Y/Y)
Research and development
$2,955K
(-35.11%↓ Y/Y)
Cost of goods sold
$283K
(1921.43%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics, Inc. (BTAI)